Hematology TimesEmicizumab reduces bleeds in kids with hemophilia A and inhibitorsDecember 11, 2017ThrombosisPediatricsBleeding Disorders
Hematology NewsIntrabone gene therapy shows promise in beta-thalassemiaDecember 10, 2017Bleeding Disorders
Hematology NewsGene therapy normalized or near-normalized factor VIII in hemophilia ADecember 10, 2017Bleeding Disorders
Hematology NewsHAVEN 2: Emicizumab represents new standard of care for hemophilia A with inhibitorsDecember 9, 2017Bleeding Disorders
Hematology NewsPolymerization inhibitor improves hemoglobin levels in adolescents with SCDDecember 9, 2017Bleeding Disorders
Hematology NewsSickle cell: Customized stem cells may improve transfusion efficacy, safetyDecember 9, 2017Bleeding Disorders
Hematology TimesGene therapy seems safe, effective in hemophilia BDecember 7, 2017ThrombosisBleeding Disorders
Hematology NewsGene therapy found promising in patients with hemophilia BDecember 6, 2017Bleeding Disorders
Hematology NewsEmpagliflozin’s heart failure benefits linked to volume dropNovember 29, 2017Bleeding Disorders
Hematology TimesFDA grants priority review to NDA for avatrombopagNovember 29, 2017AnemiaThrombosisPharmacyBleeding Disorders
Hematology NewsFDA grants orphan drug status to rofecoxib for hemophilic arthropathyNovember 22, 2017Bleeding DisordersPractice ManagementBusiness of Medicine
Hematology NewsFDA approves first-in-class drug for hemophilia A with Factor VIIINovember 18, 2017Bleeding Disorders
Hematology TimesProduct approved to treat patients with hemophilia A and inhibitorsNovember 17, 2017ThrombosisPharmacyBleeding Disorders
Hematology TimesCHMP backs therapy for hemophilia ANovember 14, 2017ThrombosisPharmacyBleeding Disorders
